GB Sciences, Inc.
GBLX
$0.0003
$0.000150.00%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 72.26% | 71.91% | 64.78% | 66.99% | 23.70% |
| Total Depreciation and Amortization | -100.00% | -100.00% | -100.00% | -99.03% | -99.24% |
| Total Amortization of Deferred Charges | -100.00% | -82.20% | -55.74% | -31.28% | -67.85% |
| Total Other Non-Cash Items | -100.00% | -103.53% | -104.15% | -102.45% | -24.97% |
| Change in Net Operating Assets | 20.67% | 55.12% | 1,664.76% | 373.33% | 216.05% |
| Cash from Operations | 46.29% | 48.32% | 33.41% | 36.10% | 52.18% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -100.00% | -63.63% | 1,112.66% | 1,112.66% | 343.16% |
| Cash from Investing | -100.00% | -63.63% | 1,112.66% | 1,112.66% | 343.16% |
| Total Debt Issued | 542.67% | 376.00% | 1,088.00% | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | 97.74% |
| Issuance of Common Stock | -97.00% | -86.89% | -83.32% | -85.13% | -80.40% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 163.12% | 155.45% | 100.00% | 100.00% | 87.04% |
| Cash from Financing | 34.24% | 14.31% | -59.72% | -61.12% | -58.04% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 94.35% | 81.51% | -22.22% | 20.90% | 79.14% |